Gyrodyne (NASDAQ:GYRO) Shares Pass Below 200 Day Moving Average – Time to Sell?

Shares of Gyrodyne , LLC (NASDAQ:GYRO) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $9.38 and traded as low as $8.18. Gyrodyne shares last traded at $7.94, with a volume of 428 shares trading hands.

Gyrodyne Trading Down 6.7%

The firm’s 50-day moving average price is $8.79 and its 200 day moving average price is $9.38.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Bulldog Investors LLP acquired a new stake in shares of Gyrodyne in the third quarter valued at approximately $601,000. Teton Advisors LLC acquired a new position in shares of Gyrodyne during the third quarter worth approximately $177,000. Susquehanna International Group LLP bought a new position in Gyrodyne in the 3rd quarter worth approximately $142,000. Finally, Advisory Services Network LLC bought a new position in Gyrodyne in the 3rd quarter worth approximately $77,000. Institutional investors own 71.36% of the company’s stock.

Gyrodyne Company Profile

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.